FDA rejects MDMA-assisted therapy for PTSD treatment – a drug researcher explains the challenges psychedelics face
(Version anglaise seulement)
par Benjamin Y. Fong, Honors Faculty Fellow, Associate Teaching Professor, and Associate Director of the Center for Work & Democracy, Arizona State University
The FDA’s decision shines a light on some of the unique obstacles that psychedelic drugs may face on the path to approval.
Lire l'article complet
© La Conversation
-
lundi 12 août 2024
